At TRACER, accurate data is in our DNA. We front run with a passion for precision to lead you to faster and better decision-making. Offering fast customised quality through our unique working methodology.
Go van Dam, CEO
Prof G.M. Van Dam, MD, PhD
Implementation and benchmarking of a novel analytical framework to clinically evaluate tumor-specific fluorescent tracers.Koller M, Qiu SQ, Linssen MD, Jansen L, Kelder W, de Vries J, Kruithof I, Zhang GJ, Robinson DJ, Nagengast WB, Jorritsma-Smit A, van der Vegt B, van Dam GM. Nat Commun. 2018 Sep 18;9(1):3739. doi: 10.1038/s41467-018-05727-y. PubMed PMID: 30228269; PubMed Central PMCID: PMC6143516.
Meet up with the TRACER team at the upcoming events.